Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-06-04 , DOI: 10.1056/nejmoa2200075
Jeanne Tie ₁ , Joshua D Cohen ₁ , Kamel Lahouel ₁ , Serigne N Lo ₁ , Yuxuan Wang ₁ , Suzanne Kosmider ₁ , Rachel Wong ₁ , Jeremy Shapiro ₁ , Margaret Lee ₁ , Sam Harris ₁ , Adnan Khattak ₁ , Matthew Burge ₁ , Marion Harris ₁ , James Lynam ₁ , Louise Nott ₁ , Fiona Day ₁ , Theresa Hayes ₁ , Sue-Anne McLachlan ₁ , Belinda Lee ₁ , Janine Ptak ₁ , Natalie Silliman ₁ , Lisa Dobbyn ₁ , Maria Popoli ₁ , Ralph Hruban ₁ , Anne Marie Lennon ₁ , Nicholas Papadopoulos ₁ , Kenneth W Kinzler ₁ , Bert Vogelstein ₁ , Cristian Tomasetti ₁ , Peter Gibbs ₁ ,

Affiliation

From the Division of Personalised Oncology, Walter and Eliza Hall Institute of Medical Research (J.T., R.W., M.L., B.L., P.G.), the Department of Medical Oncology, Peter MacCallum Cancer Centre (J.T., B.L.), the Department of Medical Oncology, Western Health (J.T., S.K., M.L., P.G.), the Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne (J.T., P.G.), the Department of Medical Oncology, Eastern Health (R.W., M.L.), the Eastern Health Clinical School, Faculty of Medicine, Nursing, and Health Sciences, Monash University (R.W., M.L.), the Department of Medical Oncology, Cabrini Health (J.S.), the Department of Medical Oncology, Monash Health (M.H.), the Department of Medical Oncology, St. Vincent's Hospital (S.-A.M.), and the Department of Medical Oncology, Northern Health (B.L.), Melbourne, VIC, the Research and Biostatistics Group, Melanoma Institute Australia, and the Faculty of Medicine and Health, University of Sydney, Sydney (S.N.L.), the Department of Medical Oncology, Bendigo Health, Bendigo, VIC (S.H.), the Department of Medical Oncology, Fiona Stanley Hospital, and Edith Cowan University, Perth, WA (A.K.), the Department of Medical Oncology, Royal Brisbane and Women's Hospital, and the University of Queensland, Brisbane, QLD (M.B.), Newcastle Private Hospital (J.L.), and the Department of Medical Oncology, Calvary Mater Newcastle Hospital (F.D.), Newcastle, NSW, the Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS (L.N.), and South West Healthcare, Warrnambool, VIC (T.H.) - all in Australia; the Ludwig Center for Cancer Genetics and Therapeutics (J.D.C., Y.W., J.P., N.S., L.D., M.P., N.P., K.W.K., B.V.), the Division of Biostatistics and Bioinformatics (K.L., C.T.), Department of Oncology, Sidney Kimmel Comprehensive Cancer Center (J.D.C., Y.W., J.P., N.S., L.D., M.P., R.H., A.M.L., N.P., K.W.K., B.V.), the Sol Goldman Pancreatic Cancer Research Center (J.D.C., Y.W., J.P., N.S., L.D., M.P., R.H., A.M.L., N.P., K.W.K., B.V.), and the Departments of Pathology (R.H.) and Medicine (A.M.L.), Johns Hopkins University School of Medicine, the Howard Hughes Medical Institute (J.P., N.S., B.V.), the Department of Biomedical Engineering, Johns Hopkins University (J.D.C.), and the Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health (C.T.) - all in Baltimore; and the Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia (S.N.L.).

New England Journal of Medicine, Ahead of Print.

中文翻译：